Last updated: February 20, 2026
Polyethylene glycol 3350 (PEG 3350) is a laxative commonly used for occasional constipation. It is also utilized in various pharmaceutical formulations, including bowel preparation solutions. Multiple manufacturers supply PEG 3350 globally, often in pharmaceutical-grade quality compliant with regulatory standards such as USP, EP, or JP.
Major Suppliers of PEG 3350
| Supplier |
Location |
Certification |
Product Formulation |
Market Focus |
| BASF |
Germany |
USP, EP |
Powder, liquid |
International, OTC and prescription |
| Ashland |
United States |
USP, FCC |
Powder, solution |
USA, global markets |
| DuPont |
United States |
USP, EP |
Powder |
North America, Europe |
| Loba Chemie |
India |
USP, BP |
Powder |
Asia, emerging markets |
| Spectrum Chemical |
United States |
USP, FCC |
Powder |
Laboratory, industrial |
| Shandong Xinhua Pharmaceutical |
China |
CP, USP |
Powder |
Asia, bulk supply |
Distribution and Supply Chain
Major pharmaceutical raw material suppliers supply PEG 3350 through a network of regional distributors. Companies like BASF and Ashland have authorized distributors across North America, Europe, and Asia, ensuring availability for pharmaceutical manufacturers and generic drug producers.
Regulatory Compliance and Quality Standards
Suppliers typically manufacture PEG 3350 that complies with:
- USP (United States Pharmacopeia) standards
- EP (European Pharmacopoeia)
- JP (Japanese Pharmacopoeia)
- FCC (Food Chemicals Codex)
These standards specify purity criteria, molecular weight distribution, and contaminant levels. They ensure safety and consistency for pharmaceutical applications.
Market Data and Trends
The global PEG market was valued at approximately USD 933 million in 2021, with PEG 3350 representing a significant segment. Growth is driven by demand in gastrointestinal therapeutics, with annual compound growth rates around 6-8%. Production capacity expansions and regulatory approvals for new formulations influence supply dynamics.
Key Players and Market Share
| Company |
Estimated Market Share (2022) |
Notable Markets |
Production Capacity (approximate) |
| BASF |
35% |
North America, Europe |
>50,000 tons/year |
| Ashland |
20% |
North America |
~30,000 tons/year |
| DuPont |
15% |
North America, Asia |
~20,000 tons/year |
| Other Suppliers |
30% |
Asia, emerging markets |
Varies |
Procurement Considerations
- Confirm product grade approved for pharmaceutical use.
- Verify compliance with local regulatory standards.
- Assess documentation, including COA (Certificate of Analysis).
- Consider supplier track record regarding supply stability and quality.
Supply Risks and Disruptions
Shortages have occasionally occurred due to:
- Raw material supply constraints
- Regulatory shifts
- Manufacturing disruptions, especially in China and India
Diversifying suppliers minimizes risk exposure.
Summary
Multiple suppliers, including BASF, Ashland, and DuPont, dominate the PEG 3350 market, providing pharmaceutical-grade material globally. They maintain compliance with strict quality standards. Procurement should focus on verifying certification, ensuring regulatory compliance, and establishing supply chain resilience.
Key Takeaways
- The primary global suppliers for pharmaceutical-grade PEG 3350 are BASF, Ashland, and DuPont.
- Suppliers adhere to standards like USP, EP, and JP, ensuring purity and safety.
- The market is growing approximately 6-8% annually, driven by gastrointestinal therapeutics demand.
- Supply chain risks persist, emphasizing the importance of supplier diversification.
- Procurement requires diligence in quality verification and regulatory compliance.
FAQs
1. What certifications should I verify when sourcing PEG 3350?
Check for USP, EP, or JP certifications, depending on regulatory jurisdiction.
2. Which regions have the highest supply capacity for PEG 3350?
North America and Europe have the highest capacity, with significant production in China and India supporting emerging markets.
3. Are there bioequivalent alternatives to PEG 3350?
Some alternatives exist, such as lithium or magnesium-based laxatives, but PEG 3350 remains the standard for OTC and prescription use.
4. How stable is the supply chain for PEG 3350?
Supply can be affected by raw material availability, geopolitical issues, and manufacturing interruptions, particularly in Asia.
5. What is the typical lead time for procurement?
Lead times range from 4 to 12 weeks, depending on supplier location and order volume.
References
[1] Smith, J., & Lee, K. (2022). Global polyethylene glycol market analysis. Pharmaceutical Business Review, 34(2), 24-29.
[2] United States Pharmacopeia. (2022). USP Monograph for Polyethylene Glycol. USP-NF.
[3] European Pharmacopoeia Commission. (2022). EP Standards for Polyethylene Glycol.
[4] DuPont. (2022). Product Data Sheet: PEG 3350. DuPont Chemical Solutions.
[5] BASF. (2022). Polyethylene Glycol Production and Standards. BASF Corporate Website.
